Trial · NCT01966120
Adverse events28
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 28
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Application site pain | General disorders | BF-200 ALA | 53 | 55 | 162 |
| other | Application site pain | General disorders | Placebo to BF-200 ALA | 16 | 32 | 30 |
| other | Application site erythema | General disorders | BF-200 ALA | 51 | 55 | 76 |
| other | Application site erythema | General disorders | Placebo to BF-200 ALA | 11 | 32 | 14 |
| other | Application site pruritus | General disorders | BF-200 ALA | 21 | 55 | 25 |
| other | Application site pruritus | General disorders | Placebo to BF-200 ALA | 9 | 32 | 10 |
| other | Application site scab | General disorders | BF-200 ALA | 20 | 55 | 26 |
| other | Application site scab | General disorders | Placebo to BF-200 ALA | 1 | 32 | 1 |
| other | Application site exfoliation | General disorders | BF-200 ALA | 17 | 55 | 21 |
| other | Application site exfoliation | General disorders | Placebo to BF-200 ALA | 1 | 32 | 1 |
| other | Application site oedema | General disorders | BF-200 ALA | 12 | 55 | 14 |
| other | Application site oedema | General disorders | Placebo to BF-200 ALA | 1 | 32 | 1 |
| other | Application site vesicles | General disorders | BF-200 ALA | 6 | 55 | 6 |
| other | Application site vesicles | General disorders | Placebo to BF-200 ALA | 0 | 32 | 0 |
| other | Application site discomfort | General disorders | BF-200 ALA | 5 | 55 | 7 |
| other | Application site discomfort | General disorders | Placebo to BF-200 ALA | 0 | 32 | 0 |
| other | Application site discharge | General disorders | BF-200 ALA | 3 | 55 | 5 |
| other | Application site discharge | General disorders | Placebo to BF-200 ALA | 0 | 32 | 0 |
| other | Nasopharyngitis | Infections and infestations | BF-200 ALA | 6 | 55 | 7 |
| other | Nasopharyngitis | Infections and infestations | Placebo to BF-200 ALA | 0 | 32 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01966120/events